Mercer Global Advisors’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$62.2K Buy
189,328
+165,345
+689% +$260K ﹤0.01% 3106
2025
Q4
$74.3K Buy
23,983
+8,239
+52% +$23.5K ﹤0.01% 2753
2025
Q3
$41.4K Buy
+15,744
New +$34.7K ﹤0.01% 2598

Other funds holding GOSS

Mercer Global Advisors's GOSS Position: Q1 2026 in Review

Mercer Global Advisors increased its Gossamer Bio (GOSS) stake by 689% in Q1 2026, buying an estimated $260K and bringing the position to 189,328 shares worth $62.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3106.

Mercer Global Advisors first reported a position in GOSS in Q3 2025 and has held it in 3 quarters since. The position peaked at $74.3K in Q4 2025. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Mercer Global Advisors held 189,328 shares of Gossamer Bio worth $62.2K as of Q1 2026.
  • Mercer Global Advisors bought 165,345 Gossamer Bio shares in Q1 2026, an estimated $260K.
  • Gossamer Bio made up ﹤0.01% of Mercer Global Advisors's portfolio in Q1 2026, its #3106 holding.
  • Mercer Global Advisors first reported a position in Gossamer Bio in Q3 2025 and has held it in 3 quarters since.
  • Mercer Global Advisors's Gossamer Bio position peaked at $74.3K in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.